MATHEMATICAL MODEL FOR PREDICTING SURVIVAL IN PATIENTS WITH  TRIPLE NEGATIVE BREAST CANCER

Atakhanova N. E., Almuradov A., Almuradova D. M., Ziyaev Sh. V

dc.contributor.author	Atakhanova N. E., Almuradov A., Almuradova D. M., Ziyaev Sh. V
dc.date.accessioned	2023-12-06T13:04:39Z
dc.date.available	2023-12-06T13:04:39Z
dc.date.issued	2023
dc.identifier.issn	2776-0960
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/9572
dc.description.abstract	Triple negative breast cancer (TNBC) has a more aggressive clinical course compared to other breast cancer subtypes. The presence of a triple negative receptor status causes the ineffectiveness of such types of targeted treatment as hormonal therapy and targeted therapy with Herceptin , in contrast to luminal and Her-2/ neu -positive tumors. In this regard, chemotherapy today remains the only accepted method of systemic treatment in this category of patients. Over the past few years, great advances have been made in the comprehensive treatment of TNBC. But, despite this, TN breast cancer remains one of the aggressive forms of malignant breast tumors with a high level of metastasis and low survival compared to other subtypes of breast cancer	en_US
dc.language.iso	en_US	en_US
dc.publisher	Researchjet Journal of Analysis and Inventions	en_US
dc.subject	triple negative breast cancer , immunohistochemistry, androgen receptor , mathematical models	en_US
dc.title	MATHEMATICAL MODEL FOR PREDICTING SURVIVAL IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER	en_US
dc.type	Article	en_US